Terms And Conditions
  1. Home
  2. Terms And Conditions
AVITA Medical, Inc (ASX: AVH): Expanded its a...
By ACE Investors / 25 Jun 2024
Read More
Medtronic Plc. (NYSE: MDT): Delivered consist...
By ACE Investors / 24 Jun 2024
Read More
Exscientia Limited (NASDAQ: EXAI): Precision ...
By ACE Investors / 20 Jun 2024
Read More
Dimerix Limited (ASX: DXB): Should Investors ...
By ACE Investors / 20 Jun 2024
Read More
Little Green Pharma (ASX: LGP): LGP has furth...
By ACE Investors / 19 Jun 2024
Read More
Mesoblast Limited (ASX: MSB) Substantially Ad...
By ACE Investors / 18 Jun 2024
Read More
Cyclopharm Limited (ASX: CYC) – Exponential...
By ACE Investors / 13 Jun 2024
Read More
Medadvisor Limited (ASX: MDR): Continued Grow...
By ACE Investors / 28 May 2024
Read More
Aroa Biosurgery Limited (ASX: ARX) Well Estab...
By ACE Investors / 28 May 2024
Read More
Regis Healthcare Limited (ASX: REG): Pursue S...
By ACE Investors / 24 May 2024
Read More
Trajan Group Holdings Limited (ASX: TRJ): Ran...
By ACE Investors / 23 May 2024
Read More
Paradigm Biopharmaceuticals Limited (ASX: PAR...
By ACE Investors / 23 May 2024
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors